SGB-1,534
Изглед
Nazivi | |
---|---|
Preferisani IUPAC naziv
3-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-1H-quinazoline-2,4-dione;hydrochloride | |
Drugi nazivi
SGB 1534 • SGB-1534
| |
Identifikacija | |
3D model (Jmol)
|
|
| |
Svojstva | |
C21H25ClN4O3 | |
Molarna masa | 416,91 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
SGB-1,534 je antagonist alfa adrenergičkog receptora.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Takaki Koga; Yasuyuki Shiraki; Kazushige Sakai (1989). „Characterization of a Novel α1-Adrenoceptor Antagonist, SGB-1534, in Contractile Response of Isolated Canine Arterial and Venous Smooth Muscle to Exogenous Noradrenaline: Comparison with Prazosin, Phentolamine and Yohimbine”. Japanese Journal of Pharmacology. 50 (2): 185—193. doi:10.1016/S0021-5198(19)42471-2.